Quantification of the six major α-dicarbonyl contaminants in peritoneal dialysis fluids by UHPLC/DAD/MSMS

Analytical and Bioanalytical Chemistry

Volumn 401, Issue 4, 2011, Pages 1183-1193

  Mittelmaier, Stefan ^a   Fünfrocken, Michael ^b   Fenn, Dominik ^b   Berlich, Robert ^b   Pischetsrieder, Monika ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b FRESENIUS MEDICAL CARE   (Germany)

Author keywords

Dicarbonyl compounds; 3,4 DGE; Glucose degradation products; Peritoneal dialysis fluids; Tandem mass spectrometry; UHPLC

Indexed keywords

3,4-DGE; DICARBONYL COMPOUNDS; GLUCOSE DEGRADATION PRODUCTS; PERITONEAL DIALYSIS; TANDEM MASS SPECTROMETRY; UHPLC;

BIOCOMPATIBILITY; DEGRADATION; FLUIDS; GLUCOSE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

DIALYSIS;

DEOXYGLUCOSE; DIALYSIS FLUID; GLUCOSONE; GLYOXAL; KETOSE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; EQUIPMENT; HUMAN; INSTRUMENT STERILIZATION; PERITONEAL DIALYSIS; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

DEOXYGLUCOSE; DIALYSIS SOLUTIONS; EQUIPMENT CONTAMINATION; GLYOXAL; HUMANS; KETOSES; MOLECULAR STRUCTURE; PERITONEAL DIALYSIS; REPRODUCIBILITY OF RESULTS; STERILIZATION; TANDEM MASS SPECTROMETRY;

EID: 80052565204     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-011-5195-9     Document Type: Article

References (25)

1. Sharma A, Blake PG (2007) Peritoneal dialysis. In: Brenner BM (ed) Brenner and Rector's the kidney. Elsevier Saunders, Philadelphia, pp 2007-2037
2. I Ledebo A Wieslander P Kjellstrand 2000 Can we prevent the degradation of glucose in peritoneal dialysis solutions? Perit Dial Int 20 SUPPL. 2 S48 S51
3. M Frischmann J Spitzer M Fünfrocken S Mittelmaier M Deckert T Fichert M Pischetsrieder 2009 Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids Biomed Chromatogr 23 8 843 851 10.1002/bmc.1194 1:CAS:528:DC%2BD1MXpt1Wlt74%3D
4. A Tauer T Knerr T Niwa TP Schaub C Lage J Passlick-Deetjen M Pischetsrieder 2001 In vitro formation of N[epsilon]-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis Biochem Biophys Res Comm 280 5 1408 1414 10.1006/bbrc.2001.4294 1:CAS:528:DC%2BD3MXptlGjtg%3D%3D (Pubitemid 32917803)
5. A Mahiout G Ehlerding R Brunkhorst 1996 Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients Nephrol Dial Transplant 11 SUPPL. 5 2 6 (Pubitemid 27062902)
6. K Honda K Nitta S Horita W Yumura H Nihei R Nagai K Ikeda S Horiuchi 1999 Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration Nephrol Dial Transplant 14 6 1541 1549 10.1093/ndt/14.6.1541 1:STN:280:DyaK1MzhtVeqtw%3D%3D (Pubitemid 29241752)
7. AS Vriese 2005 The John F. Maher recipient lecture 2004: rage in the peritoneum Perit Dial Int 25 1 8 11 (Pubitemid 40378488)
8. J Witowski K Korybalska J Wisniewska A Breborowicz GM Gahl U Frei J Passlick-Deetjen A Jorres 2000 Effect of glucose degradation products on human peritoneal mesothelial cell function J Am Soc Nephrol 11 4 729 739 1:CAS:528:DC%2BD3cXisFertL0%3D (Pubitemid 30171882)
9. LW Morgan A Wieslander M Davies T Horiuchi Y Ohta MJ Beavis KJ Craig JD Williams N Topley 2003 Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration Kidney Int 64 5 1854 1866 10.1046/j.1523-1755.2003.00265.x 1:CAS:528:DC%2BD3sXpsVCrtL8%3D (Pubitemid 37323717)
10. D-H Lee S-Y Choi H-M Ryu C-D Kim S-H Park H-Y Chung I-S Kim Y-L Kim 2009 3,4-Dideoxyglucosone-3-ene induces apoptosis in human peritoneal mesothelial cells Perit Dial Int 29 1 44 51 1:CAS:528:DC%2BD1MXjvFWksro%3D
11. T Tomo E Okabe T Yamamoto S Namoto T Iwashita K Matsuyama J Kadota M Nasu 2005 Synergistic cytotoxicity of acidity and 3,4-dideoxyglucosone-3-ene under the existence of lactate in peritoneal dialysis fluid Ther Apher Dial 9 2 182 187 10.1111/j.1774-9987.2005.00228.x 1:CAS:528:DC%2BD2MXlsFejtrY%3D (Pubitemid 40734782)
12. B Rippe O Simonsen O Heimbürger A Christensson B Haraldsson G Stelin L Weiss F-D Nielsen S Bro M Friedberg A Wieslander 2001 Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products Kidney Int 59 1 348 357 10.1046/j.1523-1755.2001.00497.x 1:CAS:528: DC%2BD3MXot1yltQ%3D%3D (Pubitemid 32055244)
13. JD Williams N Topley KJ Craig RK Mackenzie M Pischetsrieder C Lage J Passlick-Deetjen 2004 The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane Kidney Int 66 1 408 418 10.1111/j.1523-1755.2004.00747.x (Pubitemid 38870119)
14. HY Lee HC Park BJ Seo JY Do SR Yun HY Song YH Kim YL Kim DJ Kim YS Kim C Ahn MJ Kim SK Shin 2005 Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (balance) Perit Dial Int 25 3 248 255 (Pubitemid 40724205)
15. S Mortier D Faict NH Lameire AS Vriese 2005 Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model Kidney Int 67 4 1559 1565 10.1111/j.1523-1755.2005.00237.x 1:CAS:528:DC%2BD2MXjsV2lsrw%3D (Pubitemid 40463136)
16. S Mittelmaier M Fünfrocken D Fenn T Fichert M Pischetsrieder 2010 Identification and quantification of the glucose degradation product glucosone in peritoneal dialysis fluids by HPLC/DAD/MSMS J Chromatogr B Analyt Technol Biomed Life Sci 878 11-12 877 882 1:CAS:528:DC%2BC3cXjs1Olt7o%3D
17. S Mittelmaier M Fünfrocken D Fenn M Pischetsrieder 2011 3-Deoxygalactosone, a new glucose degradation product in peritoneal dialysis fluids: identification, quantification by HPLC/DAD/MSMS and its pathway of formation Anal Bioanal Chem 399 4 1689 1697 10.1007/s00216-010-4456-3 1:CAS:528:DC%2BC3cXhsFajurnI
18. CB Nilsson-Thorell N Muscalu AH Andren PT Kjellstrand AP Wieslander 1993 Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes Perit Dial Int 13 3 208 213 1:STN:280:DyaK3sznvFSmtw%3D%3D (Pubitemid 23235969)
19. T Linden G Forsback R Deppisch T Henle A Wieslander 1998 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis Perit Dial Int 18 3 290 293 1:STN:280:DyaK1czislShtA%3D%3D (Pubitemid 28365121)
20. T Linden A Cohen R Deppisch P Kjellstrand A Wieslander 2002 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis Kidney Int 62 2 697 703 10.1046/j.1523-1755. 2002.00490.x 1:CAS:528:DC%2BD38Xmt1GlsLg%3D (Pubitemid 34779784)
21. MA Glomb R Tschirnich 2001 Detection of α-dicarbonyl compounds in Maillard reaction systems and in vivo J Agric Food Chem 49 11 5543 5550 10.1021/jf010148h 1:CAS:528:DC%2BD3MXnvVOltrs%3D (Pubitemid 33089705)
22. EFLJ Anet 1961 Degradation of carbohydrates. II. Action of acid and alkali on 3-deoxyhexosones Aust J Chem 14 295 301 10.1071/CH9610295 1:CAS:528:DyaF3MXhtFWkt7w%3D
23. M Erixon A Wieslander T Linden O Carlsson G Forsback E Svensson JA Jonsson P Kjellstrand 2006 How to avoid glucose degradation products in peritoneal dialysis fluids Perit Dial Int 26 4 490 497 1:CAS:528: DC%2BD28XptFWrs7s%3D (Pubitemid 44339982)
24. M Erixon T Linden P Kjellstrand O Carlsson M Ernebrant G Forsback A Wieslander JA Jonsson 2004 PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization Perit Dial Int 24 4 392 398 1:CAS:528:DC%2BD2cXps1Kksrw%3D (Pubitemid 39206636)
25. P Kjellstrand M Erixon A Wieslander T Linden E Martinson 2004 Temperature: the single most important factor for degradation of glucose fluids during storage Perit Dial Int 24 4 385 391 1:CAS:528:DC%2BD2cXps1Kksr8%3D (Pubitemid 39206635)